RxDoctor Payments Data

Adam Fleischer

Foot & Ankle Surgery · Chicago, ILNPI 1932111606

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.9%), education and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Medwest Associates at 36.8% of the total. Reporting peaked in 2021 at $3,284 and has fallen 85.9% since, to $463 in 2025.

$9,682in general payments, 2019–2025

Across 140 payments — averaging $69.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medwest Associates$4K
  • Smith+Nephew$2K
  • Endo Pharmaceuticals Inc.$1K
  • Stryker$631
  • Kerecis Limited$419
  • KCI USA, Inc.$250
  • plus $1K from 17 others
$1,500in research payments, 2019–2025

Across 1 payment — averaging $1500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bristol Myers Squibb$2K

What the payments were for

  • Consulting fees$2503%
  • Travel & lodging$99210%
  • Food & beverage$4,92451%
  • Education$3,51636%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,682 in reported general payments places this provider in the 80th percentile of 555 foot & ankle surgery providers in Illinois.

See all foot & ankle surgery providers in Illinois →

Medicare billing

Part B allowed, 2024
$202,811
Medicare patients
92
Services billed
768

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pentoxifylline19$478
Terbinafine Hcl20$200
Levofloxacin12$157
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$156

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Chicago

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →